The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Epitheliod sarcoma: Molecular insights into proximal versus classic variant.
 
Anna Maria Frezza
Research Funding - Advenchen Laboratories; Amgen; Arog; Bayer; Blueprint Medicines; Daiichi Sankyo; Dompé Farmaceutici; Epizyme; GlaxoSmithKline; Karyopharm Therapeutics; Lilly; Novartis; Pfizer; PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Luca Sigalotti
No Relationships to Disclose
 
Elisa Del Savio
No Relationships to Disclose
 
Davide Baldazzi
No Relationships to Disclose
 
Marta Sbaraglia
No Relationships to Disclose
 
Alberto Righi
No Relationships to Disclose
 
Marco Gambarotti
No Relationships to Disclose
 
Marta Barisella
No Relationships to Disclose
 
Silvia Brich
No Relationships to Disclose
 
Angelo Paolo Dei Tos
No Relationships to Disclose
 
Silvia Stacchiotti
Honoraria - Lilly; PharmaMar; Takeda
Consulting or Advisory Role - Bavarian Nordic; Bayer; Daiichi Sankyo; Deciphera; Epizyme; Immune Design; Lilly; MaxiVax; PharmaMar
Research Funding - Advenchen Laboratories (Inst); Amgen (Inst); Bayer (Inst); Blueprint Medicines; Daiichi Sankyo (Inst); Epizyme (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - PharmaMar
 
Roberta Maestro
No Relationships to Disclose